Spanish trial shows stem cells may reverse bone loss
Spanish researchers conducted a first clinical trial showing engineered stem cells can significantly reduce fractures in patients with advanced osteoporosis.
Scientists engineered mesenchymal stem cells with a sugar coating to guide them back to bone marrow tissue effectively. This method allowed the cells to reach their target location where they could potentially repair damaged skeletal structures inside the human body.
The study tracked ten women over fifty who received a single infusion of these specially modified cells from their own marrow. Participants experienced a dramatic drop in fragility fractures, falling from an average of eight per year to just half a year later.
Bone biopsies taken four months after treatment revealed that bone tissue area grew substantially across the group. These findings suggest the therapy might actually reverse some bone loss rather than simply slowing down the natural disease progression process.
Two years later, participants reported a 34% decrease in bone pain alongside a 30% reduction in disability scores. Although no control group existed, the results indicate the treatment caused the positive changes seen in the patients.

